what are the Recommendations for Choice of SAVR Versus TAVI for Patients for
Whom a Bioprosthetic AVR Is Appropriate?
In asymptomatic patients with severe AS and an LVEF <50% who are ?80 years of age and have no anatomic contraindication to transfemoral TAVI, the decision between TAVI and SAVR should follow the same recommendations as for symptomatic patients in Recommendations 1, 2, and 3 above.